作者: Colin M. MacLeod , Richard G. Hodges , Michael Heidelberger , William G. Bernhard
DOI: 10.1084/JEM.82.6.445
关键词: Population 、 Pneumonia 、 Subcutaneous injection 、 Blood serum 、 Immunization 、 Pneumococcal infections 、 Immunology 、 Medicine 、 Streptococcus pneumoniae 、 Pneumococcal pneumonia
摘要: 1. Immunization of man with 0.03 to 0.06 mg. each the capsular polysaccharides pneumococcus types I, II, V, and VII, given in a single subcutaneous injection, has been shown be effective preventing pneumonia caused by these but not that due heterologous types. 2. Immunity appears within period 2 weeks following injection polysaccharides. Its duration was determined, although 6 months can set as minimum. 3. alternate subjects population reduced greatly incidence non-immunized. 4. The carrier rate for VII lowered significantly immunized group compared controls. It is suggested an over-all reduction carriers responsible rates pneumococcal non-immunized group.